[PDF][PDF] Subcutaneous cavernous hemangioma visualized on an indium-111-octreotide scan
PF Winter, J Lapke, R Winek - Journal of Nuclear Medicine, 1996 - Soc Nuclear Med
Indium-i 1i-octreotide, a somatostatin analog, is the first commer ciallyavailable receptor-
based agent. Itshares the binding site of naturally occurring somatostatin and is suitable for …
based agent. Itshares the binding site of naturally occurring somatostatin and is suitable for …
Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan)
JO Olsen, RV Pozderac, G Hinkle, T Hill… - Seminars in nuclear …, 1995 - Elsevier
Somatostatin, a naturally occurring 14-amino acid peptide, can be thought of as an anti-
growth hormone and functional down-regulator of sensitive tissue. Most neuroendocrine …
growth hormone and functional down-regulator of sensitive tissue. Most neuroendocrine …
Somatostatin receptor imaging: current status and future perspectives
KH Bohuslavizki - Journal of Nuclear Medicine, 2001 - Soc Nuclear Med
The neuropeptide somatostatin—a cyclic tetradecapeptide first isolated from ovine
hypothalamus (1)—is the most widely distributed of the hypothalamic releasing hormones in …
hypothalamus (1)—is the most widely distributed of the hypothalamic releasing hormones in …
Somatostatin receptor imaging in CNS tumours using 111In-octreotide
CL Maini, R Sciuto, A Tofani, A Ferraironi… - Nuclear medicine …, 1995 - journals.lww.com
This study evaluates the in vivo visualization of somatostatin (SS) receptors in central
nervous system (CNS) tumours using 111 In-octreotide imaging and discusses the clinical …
nervous system (CNS) tumours using 111 In-octreotide imaging and discusses the clinical …
Somatostatin receptor imaging in intracranial tumours
M Schmidt, K Scheidhauer, C Luyken, E Voth… - European journal of …, 1998 - Springer
The somatostatin analogue [111 In-DTPA-d-Phe 1]-octreotide (111 In-octreotide) allows
scintigraphic visualization of somatostatin receptor-expressing tissue. While it is well known …
scintigraphic visualization of somatostatin receptor-expressing tissue. While it is well known …
Somatostatin receptor imaging of neuroendocrine tumors: from agonists to antagonists
L Bodei, WA Weber - Journal of Nuclear Medicine, 2018 - Soc Nuclear Med
The last 2 years have brought significant progress for the clinical use of somatostatin
receptor (SSR) targeted imaging and therapy in the United States. In 2016, the Food and …
receptor (SSR) targeted imaging and therapy in the United States. In 2016, the Food and …
[HTML][HTML] Octreotide scan
Octreotide scan is also known as somatostatin receptor scintigraphy. This scintigraphy is
useful in the detection of carcinoid tumors and various neuroendocrine tumors …
useful in the detection of carcinoid tumors and various neuroendocrine tumors …
[CITATION][C] Clinical relevance of somatostatin receptor imaging
JC Reubi - European journal of endocrinology, 1994 - academic.oup.com
Comparative studies measuring somatostatin receptors in vitro and octreotide effect on
hormonal hypersecretion in vivo in such patients demonstrated clearly that the somatostatin …
hormonal hypersecretion in vivo in such patients demonstrated clearly that the somatostatin …
Comparison of In-111 octreotide scintigraphy with Tc-99m Hynic Toc/Tate scintigraphy in the same patient group for diagnosis of somatostatin receptor expressing …
L Kabasakal, S Sager, S Yilmaz, M Ocak, M Altiparmak… - 2006 - Soc Nuclear Med
1650 Objectives: In-111 labelled Octreotide scintigraphy has been shown to be a valuable
tool for the diagnosis of somatostatin expressing tumours and this method has been widely …
tool for the diagnosis of somatostatin expressing tumours and this method has been widely …
Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging
Recent studies have highlighted the high sensitivity of PET imaging with 68Ga-labeled
octreotide derivatives for the detection and staging of neuroendocrine tumors. A …
octreotide derivatives for the detection and staging of neuroendocrine tumors. A …